Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (1,210 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
Measure of the maximum amount of air that can be expelled in a given number of seconds during a forced vital capacity determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Expiratory Volume, Forced; Expiratory Volumes, Forced; Forced Expiratory Volumes; Volume, Forced Expiratory; Volumes, Forced Expiratory; Forced Vital Capacity, Timed; Timed Vital Capacity; Capacities, Timed Vital.
Where it fits in the MeSH classification
- Broader topics
- Pulmonary Ventilation
Related concepts
Research landscape
PubMed indexes 30,189 records tagged with the MeSH heading “Forced Expiratory Volume” (counts retrieved 2026-10-31). 4,504 of them (14.9%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 9,351 records.
Reviews account for 1,583 records (5.2%) and meta-analyses for 486. Randomized controlled trials number 4,925 (16.3%) as a share of all records on the topic. Randomized trials make up a comparatively large share of this literature, which means many treatment questions have been tested directly.
Show the data
| Period | Records |
|---|---|
| through 1999 | 9,203 |
| 2000-2009 | 7,131 |
| 2010-2019 | 9,351 |
| 2020 onward | 4,504 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 1,583 | 5.2% |
| Meta-analyses | 486 | 1.6% |
| Randomized controlled trials | 4,925 | 16.3% |
Method: PubMed query "Forced Expiratory Volume"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.
Reading the evidence in anatomy and physiology
Anatomy describes how body structures are built and physiology describes how they normally work, so most findings here are descriptive or mechanistic rather than evidence about treatment. Much of what is known comes from dissection, imaging, tissue studies and experiments in animals, and measurements in healthy volunteers can differ from those in people with disease or at different ages. Normal ranges vary between individuals and populations. Check whether a result was measured in people or in another species, the age and health of the participants, and the method used.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Evidence for large-scale gene-by-smoking interaction effects on pulmonary function | 2017 | Research article Design not recorded in structured metadata | 49 | cc by PMID 28082375 · DOI · PMC5837518 |
| Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study | 2016 | Research article Design not recorded in structured metadata | 40 | cc by PMID 27107713 · DOI · PMC4842294 |
| Age at menarche and lung function: a Mendelian randomization study | 2017 | Research article Design not recorded in structured metadata | 38 | cc by PMID 28624884 · DOI · PMC5591357 |
| Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients | 2022 | Research article Design not recorded in structured metadata | 10 | cc by PMID 35176055 · DOI · PMC8853536 |
Evidence for large-scale gene-by-smoking interaction effects on pulmonary function [1]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundSmoking is the strongest environmental risk factor for reduced pulmonary function.
- Closing excerpt
- ConclusionsThis study highlights the benefit of using genetic risk scores for identifying interactions missed when studying individual SNPs and shows, for the first time, that persons with the highest genetic risk for low FEV 1 /FVC may be more susceptible to the deleterious effects of smoking.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (285 words)
BackgroundSmoking is the strongest environmental risk factor for reduced pulmonary function. The genetic component of various pulmonary traits has also been demonstrated, and at least 26 loci have been reproducibly associated with either FEV 1 (forced expiratory volume in 1 second) or FEV 1 /FVC (FEV 1 /forced vital capacity). Although the main effects of smoking and genetic loci are well established, the question of potential gene-by-smoking interaction effect remains unanswered. The aim of the present study was to assess, using a genetic risk score approach, whether the effect of these 26 loci on pulmonary function is influenced by smoking.MethodsWe evaluated the interaction between smoking exposure, considered as either ever vs never or pack-years, and a 26-single nucleotide polymorphisms (SNPs) genetic risk score in relation to FEV 1 or FEV 1 /FVC in 50 047 participants of European ancestry from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) and SpiroMeta consortia.ResultsWe identified an interaction ( βint = -0.036, 95% confidence interval, -0.040 to -0.032, P = 0.00057) between an unweighted 26 SNP genetic risk score and smoking status (ever/never) on the FEV 1 /FVC ratio. In interpreting this interaction, we showed that the genetic risk of falling below the FEV /FVC threshold used to diagnose chronic obstructive pulmonary disease is higher among ever smokers than among never smokers. A replication analysis in two independent datasets, although not statistically significant, showed a similar trend in the interaction effect.ConclusionsThis study highlights the benefit of using genetic risk scores for identifying interactions missed when studying individual SNPs and shows, for the first time, that persons with the highest genetic risk for low FEV 1 /FVC may be more susceptible to the deleterious effects of smoking.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28082375 · DOI · PMC5837518
Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study [2]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundApproximately 40-60 % of patients remain sufferers of sequela of obstructive, restrictive or mixed patterns of lung disease despite treatment for pulmonary tuberculosis (PTB).
- Closing excerpt
- ConclusionThe prevalence of abnormal lung functions is high and it is associated with male sex, age older than 40 years, recurrent PTB and HIV negative status.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (192 words)
BackgroundApproximately 40-60 % of patients remain sufferers of sequela of obstructive, restrictive or mixed patterns of lung disease despite treatment for pulmonary tuberculosis (PTB). The prevalence of these abnormalities in Tanzania remains unknown.MethodsA descriptive cross-sectional study was carried out among 501 patients with PTB who had completed at least 20 weeks of treatment. These underwent spirometry and their lung functions were classified as normal or abnormal (obstructive, restrictive or mixed). Logistic regression models were used to explore factors associated with abnormal lung functions.ResultsAbnormal lung functions were present in 371 (74 %) patients. There were 210 (42 %) patients with obstructive, 65 (13 %) patients with restrictive and 96 (19 %) patients with mixed patterns respectively. Significant factors associated with abnormal lung functions included recurrent PTB (Adj OR 2.8, CI 1.274 - 6.106), Human Immunodeficiency Virus (HIV) negative status (Adj OR 1.7, CI 1.055 - 2.583), age more than 40 years (Adj OR 1.7, CI 1.080 - 2.804) and male sex (Adj OR 1.7, CI 1.123 - 2.614).ConclusionThe prevalence of abnormal lung functions is high and it is associated with male sex, age older than 40 years, recurrent PTB and HIV negative status.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27107713 · DOI · PMC4842294
Age at menarche and lung function: a Mendelian randomization study [3]
Abstract reading summary — source excerpts
- Opening excerpt
- A trend towards earlier menarche in women has been associated with childhood factors (e.
- Closing excerpt
- We found no effect on airway obstruction (FEV1/FVC).
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (303 words)
A trend towards earlier menarche in women has been associated with childhood factors (e.g. obesity) and hypothesised environmental exposures (e.g. endocrine disruptors present in household products). Observational evidence has shown detrimental effects of early menarche on various health outcomes including adult lung function, but these might represent spurious associations due to confounding. To address this we used Mendelian randomization where genetic variants are used as proxies for age at menarche, since genetic associations are not affected by classical confounding. We estimated the effects of age at menarche on forced vital capacity (FVC), a proxy for restrictive lung impairment, and ratio of forced expiratory volume in one second to FVC (FEV1/FVC), a measure of airway obstruction, in both adulthood and adolescence. We derived SNP-age at menarche association estimates for 122 variants from a published genome-wide meta-analysis (N = 182,416), with SNP-lung function estimates obtained by meta-analysing three studies of adult women (N = 46,944) and two of adolescent girls (N = 3025). We investigated the impact of departures from the assumption of no pleiotropy through sensitivity analyses. In adult women, in line with previous evidence, we found an effect on restrictive lung impairment with a 24.8 mL increase in FVC per year increase in age at menarche (95% CI 1.8-47.9; p = 0.035); evidence was stronger after excluding potential pleiotropic variants (43.6 mL; 17.2-69.9; p = 0.001). In adolescent girls we found an opposite effect (-56.5 mL; -108.3 to -4.7; p = 0.033), suggesting that the detrimental effect in adulthood may be preceded by a short-term post-pubertal benefit. Our secondary analyses showing results in the same direction in men and boys, in whom age at menarche SNPs have also shown association with sexual development, suggest a role for pubertal timing in general rather than menarche specifically. We found no effect on airway obstruction (FEV1/FVC).
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28624884 · DOI · PMC5591357
Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients [4]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundClusters of COPD patients have been reported in order to individualize the treatment program.
- Closing excerpt
- Cluster analysis of baseline traits illustrates that non-linear, clinically important differences can be achieved in the most functionally and emotionally impaired clusters and that 'the overall best functional cluster' as well as 'the low disease burden cluster' had an attenuated outcome.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (430 words)
BackgroundClusters of COPD patients have been reported in order to individualize the treatment program. Neither co-morbidity clusters, nor integrated respiratory physiomics clusters contributed to a better prediction of outcomes. Based on a thoroughly assessed set of pulmonary and extra-pulmonary traits at the start of a pulmonary rehabilitation (PR) program, we recently described seven clusters of COPD patients. The aims of this study are to confirm multidimensional differential response and to assess the potential of pulmonary and extra-pulmonary traits-based clusters to predict this multidimensional response to PR pulmonary in COPD patients.MethodsOutcomes of a 40-session PR program for COPD patients, referred by a chest physician, were evaluated based on the minimal clinically important difference (MCID) for 6-minute walk distance (6MWD), cycle endurance time, Canadian Occupational Performance Measure performance and satisfaction scores, Hospital Anxiety and Depression Scale anxiety and depression scores, MRC dyspnea grade and St George's Respiratory Questionnaire. The aforementioned response indicators were used to calculate the overall multidimensional response and patients were grouped in very good, good, moderate and poor responders. In the same way, responses to pulmonary rehabilitation were compared based on seven previously identified pulmonary and extra-pulmonary traits-based clusters.ResultsOf the whole sample, drop out was 19% and 419 patients (55.4% males, age: 64.3 ± 8.8, FEV1% of predicted: 48.9 ± 20) completed the pulmonary rehabilitation program. Very good responders had significantly worse baseline characteristics with a higher burden of disease, a higher proportion of rollator-users, higher body mass index (BMI), more limitations of activities in daily life, emotional dysfunction, higher symptoms of dyspnea and worse quality of life. Of the seven pre-identified clusters, 'the overall best functioning cluster' and 'the low disease burden cluster' both including the best 6MWD, the lowest dyspnea score and the overall best health status, demonstrated attenuated outcomes, while in 'the cluster of disabled patients', 76% of the patients improved health status with at least 2 times MCID. This 'cluster of disabled patients' as well as 'the multimorbid cluster', 'the emotionally dysfunctioning cluster', 'the overall worst-functioning cluster' and 'the physically dysfunctioning cluster' all demonstrated improvements in performance and satisfaction for occupational activities (more than 65% of patients improved with > 1MCID), emotional functioning (more than 50% of patients improved with > 1 MCID) and overall health status (more than 58%).ConclusionThe current study confirms the differential response to pulmonary rehabilitation based on multidimensional response profiling. Cluster analysis of baseline traits illustrates that non-linear, clinically important differences can be achieved in the most functionally and emotionally impaired clusters and that 'the overall best functional cluster' as well as 'the low disease burden cluster' had an attenuated outcome.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 35176055 · DOI · PMC8853536
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Minimal clinically important differences in COPD lung function [5]
- Research article Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes [6]
- Research article Decline of FEV1 by age and smoking status: facts, figures, and fallacies [7]
- Research article Systematic review of the association between lung function and Type 2 diabetes mellitus [8]
- Research article Outcomes and markers in the assessment of chronic obstructive pulmonary disease [9]
- Research article ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice [10]
References
- Aschard H, Tobin MD, Hancock DB, Skurnik D, Sood A, James A, et al.. Evidence for large-scale gene-by-smoking interaction effects on pulmonary function. . 2017. PMID 28082375 · DOI · PMC5837518
- Manji M, Shayo G, Mamuya S, Mpembeni R, Jusabani A, Mugusi F. Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study. . 2016. PMID 27107713 · DOI · PMC4842294
- Gill D, Sheehan NA, Wielscher M, Shrine N, Amaral AFS, Thompson JR, et al.. Age at menarche and lung function: a Mendelian randomization study. . 2017. PMID 28624884 · DOI · PMC5591357
- Augustin IML, Franssen FME, Houben-Wilke S, Janssen DJA, Gaffron S, Pennings HJ, et al.. Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients. . 2022. PMID 35176055 · DOI · PMC8853536
- Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005. PMID 17136971 · DOI
- Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J. 2007. PMID 17906084 · DOI
- Kerstjens HA, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax. 1997. PMID 9371217 · DOI · PMC1758654
- Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med. 2010. PMID 20722670 · DOI
- Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006. PMID 16585091 · DOI
- American Thoracic Society, European Respiratory Society. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med. 2005. PMID 16301301 · DOI
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-31.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.